HOME › Press Releases › Breast Biopsy Market worth $728.8 Million by 2020
Breast Biopsy Market worth $728.8 Million by 2020
The report “Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), by Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020”, provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with estimates and forecast of revenue.
Browse 75 market data tables and 66 figures spread through 152 pages and in-depth TOC on “Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), by Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020"
Early buyers will receive 10% customization on reports.
The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.
Factors such as increased breast cancer screening programs in different countries, the rising incidence of breast cancer among women, increased reimbursement rates in the U.S. for image-guided biopsies, and the increasing demand for less-invasive breast biopsies are the key factors driving the growth of the breast biopsy market. However, the risk of infection due to improper care of breast biopsy cuts and wounds and uncertain regulatory approval procedures for medical devices are likely to restrain the growth of the market.
The market is segmented on the basis of product, type, guidance, and region. The breast biopsy guidance market is categorized into mammography, ultrasound, MRI, and others (PET and thermography). In this market, the ultrasound segment is expected to be the fastest growing owing to the increasing demand for minimally invasive and non-radiation breast biopsy among patients and surgeons.
On the basis of type, the market is classified into needle and open surgical breast biopsy market. The needle breast biopsy segment is expected to account for the largest share of the global breast biopsy market. The large share of this segment can be attributed to the increased preference for needle biopsies over open surgical breast biopsies and the demand for scar-less and painless surgical procedures.
On the basis of region, the breast biopsy market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America is expected to account for the largest share of the breast biopsy market, followed by Europe. However, Asia-Pacific is expected to register a higher growth rate during the forecast period. The growth of the breast biopsy market in Asia-Pacific will be centered on China and India.
Major players operating in the breast biopsy market are Becton, Dickinson and Company (U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), and Hologic Inc. (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India